Prof. Stephen J. Gange

powered by
COS Expertise®
Johns Hopkins University
Bloomberg School of Public Health
Epidemiology
Professor
Professional Headshot of Stephen J. Gange

Mailing Address

Department of Epidemiology
615 N Wolfe Street
Room E7638
Baltimore, Maryland 21205
United States

Contact Information

Phone: (410) 502-9771
Fax: (410) 955-7587
Mobile: (202) 277-3366
sgange@jhsph.edu

Qualifications

Ph.D., University of Wisconsin-Madison, Statistics, 1994.
B.S., Cornell University, Animal Sciences (Emphasis in Quantitative Genetics), 1989.

Expertise and Research Interests

Research interests include epidemiologic and statistical methods for cohort studies, evaluation of therapies in observational studies, epidemiology and pathogenesis of HIV/AIDS, modeling of disease biomarkers, and data management and statistical coordinating centers.

Dr. Gange is principal investigator of the data management and analysis center for the Women's Interagency HIV Study (WIHS), a nationwide cohort study of HIV-infected women. Beginning in 2006, he has been the Epidemiology/Biostatistics Core Director for the North American AIDS Cohort Collaboration of Research and Design (NA-ACCORD), an International Epidemiologic Databases to Evaluate AIDS (IEDEA) initiative sponsored by NIAID. Since 1994 he has also been a co-investigator for the Center for the Analysis and Management of the Multicenter AIDS Cohort Study (MACS) and has worked with collaborators from the Department of Environmental Health Sciences in investigations of molecular biomarkers for environmental carcinogens.

Other Expertise

Participation on Advisory Panels:
Data Safety and Monitoring Boards:
2002-2009 Group B Streptococcus vaccine study (NIH/NIAID/DMID)
2006- Chair, Leber Congenital Amaurosis (LCA) trial (NIH/NEI)

National Institutes of Health / Centers for Disease Control & Prevention Scientific Review:
2009 Challenge Grant Reviewer
2008 Office of AIDS Research FY 2010 planning workshop for natural history and epidemiology
2007 Special emphasis review panel for "Early HIV Infection P01" (NIAID)
2007 Office of AIDS Research Co-chair, FY 2008 planning workshop for natural history and epidemiology
2006 Special emphasis review panel for U.S. Military HIV Research Program (NIAID)
2006 Office of AIDS Research Co-chair, FY 2008 planning workshop for natural history and epidemiology
2005 Office of AIDS Research FY 2007 planning workshop for natural history and epidemiology
2004-2006 Member, NIH AIDS Clinical Studies and Epidemiology Study Section (permanent member)
2005 Special emphasis review panel for "HIV Clinical Trials Leadership Network"
2004 Office of AIDS Research FY 2006 planning workshop for natural history and epidemiology
2001-2004 Ad hoc member, NIH AIDS Clinical Studies and Epidemiology Study Section [Previously known as AIDS and Related Research (AARR-6)] (seven meetings)
2003 Special emphasis review panel for U.S. Military HIV Research Program (USMHRP)
2003 Office of AIDS Research FY 2005 planning workshop for natural history and epidemiology
2002 Ad hoc panel for review of HIV/AIDS research at National Institute of Dental and Craniofacial Research
2002 Special emphasis review panel for "Centers for AIDS Research (CFAR)" PA (NIH/NIAID)
2002 Special emphasis review panel for "Cooperative Grants for Nutritional Modulation" RFA (NIH/NCI)
2002 Special emphasis review panel for "Integrated Multi-level Interventions to Improve Adolescent Health through the Prevention of Sexually Transmitted Diseases, Including HIV, and Teen Pregnancy" PA (CDC)
2002 Office of AIDS Research FY 2004 planning workshop for natural history and epidemiology. Invited speaker on "Long-term Studies of Treated HIV Infection"
2001 Office of AIDS Research FY 2003 planning workshop for natural history and epidemiology
2001 Special emphasis review panel for "Centers for AIDS Research (CFAR)" PA (NIH/NIAID)
2001 Chair, Technical evaluation group and member of final source selection committee for "Clinical Site Operations and Monitoring Project" RFP (NIH/NIAID)
1999 Special emphasis review panel for "HIV Vaccine Network Leadership Groups" PA (NIH/NIAID)

National Institutes of Health Invited Workshops:
2007 NIAID Non-AIDS Morbidity and Mortality Workshop. Invited speaker on "Non-AIDS Morbidity and Mortality in the Multicenter AIDS Cohort Study and Women's Interagency HIV Study."
2007 NIAID HIV/AIDS Clinical Trials Strategic Working Group (SWG). Invited speaker on "The role of observational studies and clinical cohort studies in addressing long term clinical questions in HIV/AIDS."
2006-7 Planning Committe & Session Organizer for 2007 Meeting on Statistical and Methodologic Issues in HIV Reseasrch
2004 Epidemiology Branch, Basic Sciences Program, Division of AIDS, NIAID meeting on "International Databases to Evaluate AIDS (IDEA)." Invited member of panel on "Methodologic issues and standardizing databases."
2002 Office of AIDS Research / NIAID consultation on HIV studies in developing settings. Invited discussion leader on "Data acquisition, management and access"
2000 Long-term clinical studies in HIV-1 infection workshop.

Other Advisory Panels:
2007-11 Scientific Advisory Committee Member, Lifspan/Tufts/Brown Center for AIDS Research
2007 International Conference abstract review committee, 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention
2006 International conference abstract review committee, XVI International AIDS Conference
University of California-Gladstone Institute of Virology & Immunology Center for AIDS Research 2006 External Advisory Review Committee
2005 Reviewer of Force Health Protection Research Program, US Army Medical Research and Materiel Command, American Institute of Biological Sciences.
2002 International scientific review committee, XIV International AIDS Conference
2001 Forum for Collaborative HIV Research, Definition of Treatment Failure Initiative, planning committee
2000-3 Johns Hopkins center for AIDS Research, scientific steering committee (Epidemiology)
2000 Scientific reviewer for US Army Medical Research and Materiel Command Proposals, American Institute of Biological Sciences.
2000 International Scientific Review Committee, XIII International AIDS Conference
1996-9 Statistical advisory group, Health Profile of Workers in the Pulp and Paper Industry Project, Dr. Genevieve Mantanoski, Principal Investigator.
1996 Scientific advisory group, Salisbury Eye Evaluation (SEE) Project, Dr. Sheila West, Principal Investigator
1994-5 Scientific advisory board member, Chartwell Foundation, Chicago, IL.

Keywords

COS Keywords:

AIDS, Animal Genetics Or Breeding, Animal Science, Biomarkers, Cancer Or Carcinogenesis, Epidemiology, HIV, Pathogenesis, Quantitative Genetics, Statistics.

Additional Terms:

Cohort Studies, Epidemiologic Methods, HIV/AIDS.

Honors and Awards

2005, Advising, Mentoring, and Teaching Recognition Award (AMTRA), Student Assembly, Johns Hopkins Bloomberg School of Public Health
2002, Elected Member, Delta Omega Honorary Public Health Society, Johns Hopkins University
1994, Student Scholarship Travel Award, Society of Clinical Trials
1994, Student Travel Award, Biometrics Society

Funding Received

  • National Institutes of Health (NIH): Supplement to WDMAC for Statistical and Epidemiologic Support of the Tri-Services AIDS Clinical Consortium Study, 2005 to .
  • [F31-MH076656]. S. Gange, Sponsor: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Fellowship for Amy Boore, 2005 to .
  • [R36-DA021104]. S. Gange, Co-Principal Investigator and Thesis advisor: Physical Functioning in Women with HIV. Dissertation award for Arpi Terzian, 2005 to .
  • U01-AI042590: WIHS Data Management and Analysis Center, 1997 to .

Publications

  • Mansoor A, Althoff K, Gange S, Anastos K, DeHovitz J, Minkoff H, Kaplan R, Holman S, Lazar J. (2009) Elevated N-terminal-pro-brain natriuretic peptide levels are associated with comorbidities among HIV infected women, AIDS Research and Human Retroviruses, 25 (5), 475-481
  • Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, (2009) Trends in Multi-Drug Failure and Subsequent Mortality Among Antiretroviral Therapy-Experienced HIV-Infected Patients in North America, Clinical Infectious Diseases, 49 (10), 1582-1590
  • Sethi A, Gange SJ (2009) Parametric models for studying time to antiretroviral resistance associated wth illicit drug use., Wisconsin Medical Journal, 108 (5), 266-268
  • Lau B, Gange SJ, Kirk GD, and Moore RD (2009) Inferences from Clinical and Interval Cohort Studies with Application to the Evaluation of HIV Biomarkers, Epidemiology, 20 (5), 664-672
  • Silverberg MJ, Jacobson LP, French A, Witt MD, and Gange SJ (2009) Age and racial/ethnic differences in the prevalence of reported symptoms in HIV-infected persons on antiretroviral therapy, J Pain Symptom Manage, 38 (2), 197-207
  • Templeton AR, Kramer MG, Jarvis J, Kowalski J, Gange S, Schneider MF, Shao Q, Zhang GW, Yeh MF, Tsai HL, Zhang H, and Markham RB (2009) Multiple-infection and Recombination in HIV-1 Within A Longitudinal Cohort of Women, Retrovirology, 6 (1), 54
  • Lau B, Cole SR, Gange SJ (2009) Competing risk regression models for epidemiologic data, American Journal of Epidemiology, 170, 244-56
  • Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, and Gange SJ (2009) Serum Lipid Profiles among Patients Initiating Ritonavir-Boosted Atazanavir versus Efavirenz-Based Regimens, AIDS Research and Therapy, 6 (31)
  • Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, and Greenblatt RM (2009) NNRTI pharmacokinetics in a large unselected cohort of HIV-infected women, J Acquir Immune Defic Syndr, 50 (5), 482-91
  • Feldman DN, Feldman JG, Greenblatt RM, Anastos K, Pearce L, Cohen MH, Gange SJ, Leanza S, and Burk R (2009) CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women, AIDS Educ Prev, 21 (3)
  • Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F (2009) Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy, Proc Natl Acad Sci (USA), 106 (23), 9403-8
  • Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival, New England Journal of Medicine, 360, 1815-26
  • Phelan DF, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P (2009) Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women, Sex Transm Dis, 36 (3), 149-156
  • Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM (2009) Protease inhibitor levels in hair strongly predict virologic response to treatment, AIDS, 20 (4), 471-78
  • Kowalski J, Gange SJ, Schneider MF, Tsai H-L, Templeton A, Shao Q, Zhang QW, Yeh MF, Young M, and Markham RB (2009) Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene, J Acquir Immune, 50, 381-389
  • Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, Landay AL, Anastos K, Associations of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) with HIV disease progression in women, Journal of Infectious Diseases, 197(2), 319-27, 2008
  • Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, Burk RD, French AL, Kaplan RC, Young M, Gange S, Xue X, Harris TG, Anastos K, Kovacs A, The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women, AIDS, 22, 527-31, 2008
  • Gange SJ, Teaching Epidemiologic Methods, Epidemiology, 19, 353-6, 2008
  • Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, and Greenblatt RM, Consistency of initial antiretroviral therapy with HIV treatment guidelines in a representative group of HIV-infected women in the United States, JAIDS, 47(3), 377-83, 2008
  • Harris TG, Burk RD, Yu H, Minkoff H, Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, Levine AM, Moxley M, Xue X, Fazzari M, Palefsky JM, Strickler HD, The Insulin-like Growth Factor (IGF)-axis and Oncogenic Human Papillomavirus Natural History, Cancer Epidemiology, Biomarkers, & Prevention, 17(1), 245-8, 2008
  • Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, and Hodis HN, Subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected women and men, AIDS, In Press, 2008
  • Lau B, Cole SR, Moore RD, Gange SJ, Evaluating competing adverse and beneficial, Statistics in Medicine, In Press, 2008
  • Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson L, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN. (2008) Low CD4+ T-cell count as a mojor atherosclerosis risk factor in HIV-infected women and men, AIDS, 22, 1615 -24
  • Egner P, Kensler T, Chen J, Gange S, Groopman J, Friesen M (2008) Quantification of Sulforaphane Mercapturic Acid Pathway Conjugates in Human Urine by High-Performance Liquid Chromatography and Isotope-Dilution Tandem Mass Spectrometry, Chem Res Toxicol, 21 (10), 1991-96
  • Safaeian M, Kiduggavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Muroka D, Sklar M, (2008) Determinants of Incidence and Clearance of High- Risk Human Papillomavirus Infections in Rural Rakai, Uganda, Cancer Epidemiology, Biomarkers, & Prevention, 17 (6), 1300-1307
  • Safaeian M, Kiduggavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Muroka D, Sklar M, (2008) Prevalence and risk factors for carcinogenic, Sex Transm Inf, 84, 306-311
  • Golub ET*, Benning L, Sharma A, Gandhi M, Cohen M, Young M, and Gange SJ (2008) Patterns, Predictors, and Consequences of Initial Regimen Type among HIV-infected Women Initiating HAART, Clinical Infectious Diseases, 46, 305-12
  • Morris JD*, Golub ET, Mehta S, Jacobson LP, and Gange SJ, Injection Drug Use and Patterns of Highly Active Antiretroviral Therapy Use: An analysis of ALIVE, WIHS, and MACS cohorts, AIDS Research and Therapy, 4(12), 6 Jun 2007
  • Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice SC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TG, Freem, The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), International Journal of Epidemiology, 36(2), 294-301, 2007
  • Wilson TE, Vega M, Feldman J, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ, Acquisition of new sexual partners among women with HIV-infection: Patterns of disclosure and sexual behavior within new partnerships, AIDS Education and Prevention, 19(2), 151-9, 2007
  • Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J, Moore RD, Gange SJ, and Siliciano RF, Stability of the Latent Reservoir for HIV-1 in Patients on Valproic Acid, Journal of Infectious Diseases, 15(195), 833-6, 2007
  • Lau B*, Gange SJ, Moore RD, Risk of Non-AIDS Related Mortality May Exceed AIDS-Related Mortality Among Individuals Enrolling Into Care With CD4+ Counts Above 200 Cells/mm3, JAIDS, 44, 179-187, 2007
  • Persaud D, Ray S, Kajdas J, Ahonkhai A, Siberry GK, Ferguson K, Ziemniak C, Quinn TC, Casazza JP, Zeichner S, Gange SJ, Watson DC, Slow Human Immunodeficiency Virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy, AIDS Research and Human Retroviruses, 23, 381-90, 2007
  • Massad LS, Fazzari MJ, Anastos K, Klein RS, Minkoff H, Jamieson DJ, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts DH, Levine AM, Schuman P, Harris TG, Strickler HD, Outcomes after treatment of cervical intraepithelial neoplasia among women with human immunodeficiency virus, Journal of Lower Genital Tract Disease, 11, 90-7, 2007
  • Nowicki M, Karim R, Mack W, Minkoff H, Anastos K, Cohen M, Greenblatt R, Young M, Gange S, and Levine A., Correlates of CD4+ and CD8+ Lymphocyte Counts in High-Risk Immunodeficiency Virus (HIV)-Seronegative Women enrolled in the Women's Interagency HIV Study (WIHS), Human Immunology, 68, 342-9, 2007
  • Lau B*, Gange SJ, Moore RD, Interval and clinical cohort study: epidemiologic issues, AIDS Research and Human Retroviruses., 6, 769-76, 2007
  • Harris TG, Burk RD, Xue X, Anastos KA, Minkoff H, Massad LS, Young MA, Levine AM, Fazzari M, Gange SJ, Bang JY, Watts DH, Greenblatt RM, Palefsky JM, Strickler HD, Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women, AIDS, 21, 1933-41, 2007
  • Kaplan RC, Kingsley LA, Sharret AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobson LP, and Gange SJ, Ten-year predicted coronary heart disease risk in HIV-infected men and women, Clinical Infectious Diseases, 45, 1074-81, 2007
  • Lazo M*, Gange SJ, Wilson T, Ostrow D, Witt J, Jacobson LP, Patterns and Predictors of Changes in Adherence to Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, 45(10), 1377-85, 2007
  • Liu C*, Weber K, Robison E, Hu Z, Jacobson L, and Gange SJ, Asessing the Effect of HAART on Quality of Life among HIV-Infected Women, AIDS Research and Therapy, 3(6), 20 Mar 2006
  • Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, and Greenblatt R., Genotypic Resistance and Immunologic Outcomes Among HIV-1 Infected Women With Viral Failure., JAIDS, 41(1), 68-74, 2006
  • Lau B*, Sharrett AR, Kingsley L, Post W, Palella FJ, Detels R, and Gange SJ, C-Reactive Protein Is a Marker for HIV Disease Progression, Archives of Internal Medicine, 166, 64-70, 2006
  • Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Young M, Mocharnuk RS, Anastos K, Impact of Cigarette Smoking on HIV Prognosis Among Women in the HAART Era - a Report From the Women's Interagency HIV Study, American Journal of Public Health, 96, 1060-65, 2006
  • Freeman E*, Gange SJ, Muñoz B, and West S, Driving Status and Risk of Long-term Care Entry in Older Adults, American Journal of Public Health, 96, 1254-59, 2006
  • Levine AM, Karim R, Mack W, Gravink J, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, Watts DH, Neutropenia in HIV infection: Data from the Women's Interagency HIV Study, Archives of Internal Medicine, 166, 405-10, 2006
  • Golub JE*, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, and Chaisson RE, Delayed tuberculosis diagnosis and tuberculosis transmission, Int J Tuberc Lung Dis, 10(10), 24-30, 2006
  • Ameli N, Bacchetti P, Ashley R, Wilkin T, Young M, Cohen M, Kovacs A, Minkoff H, Gange SJ, and Greenblatt RM, Herpes simplex virus infections in women with HIV infection, or who are at high risk for infection: epidemiology and effects of antiretroviral therapy on clinical manifestations, AIDS, 20, 1051-8, 2006
  • Burke-Miller JK, Cook JA, Cohen MH, Hessol N, Wilson TE, Richardson JL, Williams P, and Gange SJ, The Longitudinal Relationship Between Use of Highly Active Antiretroviral Therapy and Satisfaction with Care Among Women Living with HIV/AIDS, American Journal of Public Health, 96, 1044-51, 2006
  • Chattopadhyay PK*, Douek DC, Gange SJ, Chadwick K, Hellerstein M, and Margolick JB, Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure, AIDS Research and Human Retroviruses, 22, 501-7, 2006
  • Silverberg MJ, Wegner DA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ, . Effectiveness of highly-active antiretroviral therapy by race/ethnicity, AIDS, 20, 1531-8, 2006
  • Margolick JB, Gange SJ, Detels R, O'Gorman MRG, Rinaldo C, Lai S, Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection, JAIDS, 42(5), 620-6, 2006
  • Nguyen RHN*, Gange SJ, Wabwire-Mangen F, Sewankambo NK, Serwadda D, Wawer M, Quinn TC, and Gray RH, Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda, Intl J STD and HIV, 17, 842-6, 2006
  • Cole SR, Chu H, Allison PD, Gange SJ, Combined analysis of retrospective and prospective occurrences in cohort studies: HIV-1 serostatus and incident pneumonia, International Journal of Epidemiology, 35(6), 1442-6, 2006
  • Nguyen RHN*, Gange SJ, Serwadda D, Kigozi G, Kiwanuka N, Sewankambo NK, Wabwire-Mangen F, Quinn TC, Wawer M, and Gray RH, Screening HIV-positive pregnant women for ART: Utility of self-reported symptoms, Intl J STD and HIV, 17(2), 112-115, 2006
  • Nguyen RHN*, Gange SJ, Wabwire-Mangen F, Sewankambo NK, Serwadda D, Wawer MJ, Quinn TC, and Gray RH. (2006) Reduced Fertility Among HIV-infected Women Associated With Viral Load in Rakai District, Uganda., Int J STD and HIV, 17, 842-846
  • Chu H, Gange SJ, Yamashita TE, Hoover DR, Chmiel JS, Margolick JB, Jacobson LP (Oct 2005) Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model., American Journal of Epidemiology, 162 (8), 787-97 Abstract
  • Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, Chen Z, Bang JY, Fazzari M, Hall C, Strickler HD (Oct 2005) Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women, Journal of General Virology, 86 (10), 2709-20 Abstract
  • Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE (Sep 2005) Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state., The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease., 9 (9), 992-8 Abstract
  • Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA (Sep 2005) The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench., Clinical and Diagnostic Laboratory Immunology, 12 (9), 1013-9 Abstract
  • Massad LS, Evans CT, Strickler HD, Burk RD, Watts DH, Cashin L, Darragh T, Gange S, Lee YC, Moxley M, Levine A, Passaro DJ (Sep 2005) Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities, Obstetrics & Gynecology, 106 (3), 525-32 Abstract
  • Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, Feldman J, Levine A, Delapenha R, Cohen M, for the Women's Interagency HIV Study Collaborative Group (Aug 2005) The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women., JAIDS, 39 (5), 537-44 Abstract
  • Lau B*, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB (Aug 2005) Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection., JAIDS, 39 (5), 620-5 Abstract
  • Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, Levine A, Greenblatt RM, Hormonal Contraceptive Use and the Effectiveness of Highly Active Antiretroviral Therapy., American Journal of Epidemiology, 161(9), 881-90, May 2005 Abstract
  • Golub JE, Bur S, Cronin WA, Gange S, Sterling TR, Oden B, Baruch N, Comstock GW, Chaisson RE, Impact of Empiric Antibiotics and Chest Radiograph on Delays in The Diagnosis of Tuberculosis., The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease., 9(4), 392-7, Apr 2005 Abstract
  • Schneider MF, Gange SJ, Margolick JB, Detels R, Chmiel JS, Rinaldo C, Armenian HK (Feb 2005) Application of case-crossover and case-time-control study designs in analyses of time-varying predictors of T-cell homeostasis failure., Annals of Epidemiology, 15 (2), 137-44 Abstract
  • Schneider MF*, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, and Munoz A., Patterns of the Hazard of Death After AIDS Through the Evolution of Antiretroviral Therapy: 1984 - 2004, AIDS, 19(17), 2009-18, 2005
  • Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM., Eligibility Criteria for HIV Clinical Trials and Generalizability of Results: the Gap Between Published Reports and Study Protocols., AIDS, 19, 1885-1896, 2005
  • Kensler TW, Chen J-G, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Wang J-B, Wu Y, Sun Y, Zhang Q, Zhang B, Zhu Y-R, Qian G-S, Carmella SG, Hecht SS, Benning L, Gange SJ, Groopman JD, and Talalay P, "Effects of glucosinolate-rich broccoli sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, PRC, Cancer Epidemiology Biomarkers & Prevention, 14, 2605-2613, 2005
  • Schneider MF*, Gange SJ, Margolick JB, Detels R, Chmiel JS, Rinaldo C, Armenian HK (2005) Application of case-crossover and case-time-control study designs in analyses of time-varying predictors of T-cell homeostasis failure, Annals of Epidemiology, 15, 137-144
  • Lau B, Gange SJ, Methods for the Analysis of Continuous Biomarker Assay Data With Increased Sensitivity., Epidemiology (cambridge, Mass.), 15(6), 724-32, Nov 2004 Abstract
  • Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Lu PX, Chen JG, Qian GS, Kuang SY, Jackson PE, Gange SJ, Jacobson LP, Munoz A, Groopman JD, Chemoprevention of Hepatocellular Carcinoma in Aflatoxin Endemic Areas., Gastroenterology, 127(5 Suppl 1), S310-8, Nov 2004 Abstract
  • Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Gooze L, Rubin NR, Young MA, Cai X, Shi Q, Gao W, Anastos K, Association Between Renal Disease and Outcomes Among HIV-infected Women Receiving Or Not Receiving Antiretroviral Therapy., Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America., 39(8), 1199-206, Oct 2004 Abstract
  • Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ, Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 39(5), 717-24, September 2004 Abstract
  • Philpott S, Burger H, Tarwater PM, Lu M, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young M, Miotti P, Dupuis M, Weiser B, CCR2 Genotype and Disease Progression in a Treated Population of HIV Type 1-infected Women., Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America., 39(6), 861-5, Sep 2004 Abstract
  • Barron Y, Cole SR, Greenblatt RM, Cohen MH, Anastos K, DeHovitz JA, Delapenha R, Gange SJ, Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy, Aids (london, England), 18(11), 1579-84, July 2004 Abstract
  • Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, Silver S, Robison E, Levine A, Gange SJ, Changes in sexual behavior among HIV-infected women after initiation of HAART, American Journal of Public Health, 94(7), 1141-6, July 2004 Abstract
  • Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ, Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-positive Women., Journal of the National Cancer Institute, 96(14), 1070-6, Jul 2004 Abstract
  • Szczech LA, Gange SJ, van der Horst C, Bartlett JA, Young M, Cohen MH, Anastos K, Klassen PS, Svetkey LP, Definition of proteinuria among women with HIV infection, Kidney International, 65(4), 1519, 2004 Abstract
  • Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD, Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 38(8), 1167-74, April 2004 Abstract
  • Anastos K, Barron Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ, The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy, Annals of Internal Medicine, 140(4), 256-64, 2004 Abstract
  • Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, MacPhail LA, Mulligan R, Greenspan JS, Incidence of oral lesions in HIV-1-infected women: reduction with HAART, Journal of Dental Research, 83(2), 145-50, February 2004 Abstract
  • Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA, The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 38(4), 579-84, February 2004 Abstract
  • Sethi AK*, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H (2004) High-risk behavior and potential transmission of drug-resistant HIV among injection drug users, J Acquir Immune Defic Syndr, 35, 503-510
  • Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR, Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz, Carcinogenesis, 24(12), 1919-28, 2003 Abstract
  • Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE, Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance, JAIDS, 37(8), 1112-8, October 2003
  • Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB, Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men, Aids (london, England), 17(14), 2035-44, 2003 Abstract
  • Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, Sewankambo NK, Moore R, Wabwire-Mangen F, Lutalo T, Quinn TC, Rakai Project Group, Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda, Aids (london, England), 17(13), 1941-51, 2003 Abstract
  • Burke JK, Cook JA, Cohen MH, Wilson T, Anastos K, Young M, Palacio H, Richardson J, Gange S, Dissatisfaction with medical care among women with HIV: dimensions and associated factors, Aids Care, 15(4), 451-62, 2003 Abstract
  • Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD, Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women, Journal of the National Cancer Institute, 95(14), 1062-71, 2003 Abstract
  • Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF, Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells, Nature Medicine, 9(6), 727-8, 2003 Abstract
  • Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, Williams C, Goldwasser P, Anastos K, Serum albumin is a powerful predictor of survival among HIV-1-infected women, Journal of Acquired Immune Deficiency Syndromes (1999), 33(1), 66-73, 2003 Abstract
  • Philpott S, Weiser B, Tarwater P, Vermund SH, Kleeberger CA, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young MA, Miotti P, Dupuis M, Chen CH, Burger H, CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women, The Journal of Infectious Diseases, 187(4), 569-75, 2003 Abstract
  • Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB, Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy, Aids (london, England), 17(1), 119-21, 2003 Abstract
  • Gange SJ, Lau B, Phair J, Riddler SA, Detels R, and Margolick JB (2003) Rapid declines i total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy, AIDS, 17, 119-121
  • Gruskin L, Gange SJ, Celentano D, Schuman P, Moore JS, Zierler S, Vlahov D, Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study, Journal of Urban Health : Bulletin of the New York Academy of Medicine, 79(4), 512-24, 2002 Abstract
  • Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D, Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure, Journal of Virology, 76(18), 9481-92, 2002 Abstract
  • Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Munoz A, Groopman JD, Strategies for chemoprevention of liver cancer, European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ecp)., 11 Suppl 2, S58-64, Aug 2002 Abstract
  • Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF, Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication, Journal of Virology, 76(8), 4138-44, 2002 Abstract
  • Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ, Women's Interagency HIV Study Collaborative Research Group, Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study, Journal of Acquired Immune Deficiency Syndromes (1999), 29(5), 495-503, 2002 Abstract
  • French AL, Cohen MH, Gange SJ, Burger H, Gao W, Semba RD, Meyer WA 3rd, Robison E, Anastos K, Vitamin A deficiency and genital viral burden in women infected with HIV-1, Lancet, 359(9313), 1210-2, 2002 Abstract
  • Gange SJ, Barron Y, Greenblatt RM, Anastos K, Minkoff H, Young M, Kovacs A, Cohen M, Meyer WA 3rd, Munoz A, Women's Interagency HIV Study Collaborative Study Group, Effectiveness of highly active antiretroviral therapy among HIV-1 infected women, Journal of Epidemiology and Community Health, 56(2), 153-9, 2002 Abstract
  • Szczech LA, Gange SJ, van der Horst C, Bartlett JA, Young M, Cohen MH, Anastos K, Klassen PS, Svetkey LP, Predictors of proteinuria and renal failure among women with HIV infection, Kidney International, 61(1), 195-202, 2002 Abstract
  • Gange SJ and Cole SR (2002) Review of Epidemiologic Analysis: a Case-Oriented Approach by Steven Selvin, Am J Epidemiol, 155, 485-86
  • Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW, Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer, Proceedings of the National Academy of Sciences of the United States of America., 98(25), 14601-6, December 2001 Abstract
  • Gange SJ, Mellors JW, Lau B, Detels R, Phair JP, Munoz A, Margolick JB, Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression, Aids Research and Human Retroviruses, 17(13), 1223-9, 2001 Abstract
  • Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, Greenblatt RM, Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS), Journal of the American Academy of Dermatology, 44(5), 785-8, 2001 Abstract
  • Levine AM, Berhane K, Masri-Lavine L, Sanchez M, Young M, Augenbraun M, Cohen M, Anastos K, Newman M, Gange SJ, Watts H, Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study, Journal of Acquired Immune Deficiency Syndromes (1999), 26(1), 28-35, 2001 Abstract
  • Hogben M, Gange SJ, Watts DH, Robison E, Young M, Richardson J, Cohen M, and DeHovitz J, The effect of sexual and physical violence on risky sexual behavior and STDs among a cohort of HIV seropositive women, AIDS and Behavior, 5(4), 353-361, 2001
  • DeHovitz JA, Kovacs A, Feldman JG, Anastos K, Young M, Cohen M, Gange SJ, Melnick S, Greenblatt RM, The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study, The Journal of Infectious Diseases, 182(5), 1527-30, 2000 Abstract
  • Ahdieh L, Gange SJ, Greenblatt R, Minkoff H, Anastos K, Young M, Nowicki M, Kovacs A, Cohen M, Munoz A, Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus, American Journal of Epidemiology, 152(10), 923-33, 2000 Abstract
  • Hessol NA, Anastos K, Levine AM, Ameli N, Cohen M, Young M, Augenbraun M, Miotti P, Gange SJ, Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group, Aids Research and Human Retroviruses, 16(12), 1105-11, 2000 Abstract
  • Kensler TW, Dolan PM, Gange SJ, Lee JK, Wang Q, Posner GH, Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis, Carcinogenesis, 21(7), 1341-5, 2000 Abstract
  • Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, Munoz A, Greenblatt RM, Association of race and gender with HIV-1 RNA levels and immunologic progression, Journal of Acquired Immune Deficiency Syndromes (1999), 24(3), 218-26, 2000 Abstract
  • Maas JJ, Gange SJ, Schuitemaker H, Coutinho RA, van Leeuwen R, Margolick JB, Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study, Aids (london, England), 14(9), 1155-61, 2000 Abstract
  • Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K, Nowicki M, Delapena R, Miotti P, Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study, Aids (london, England), 14(7), 863-70, 2000 Abstract
  • Munoz A, Gange SJ, Jacobson LP, Distinguishing efficacy, individual effectiveness and population effectiveness of therapies, Aids (london, England), 14(6), 754-6, 2000 Abstract
  • Wiley DJ, Visscher BR, Grosser S, Hoover DR, Day R, Gange S, Chmiel JS, Mitsuyasu R, Detels R, Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss, Aids (london, England), 14(6), 707-15, 2000 Abstract
  • Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, Chmiel JS, Zucconi SL, Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study, Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation., 9(1), 55-63, February 2000 Abstract
  • Hennessey KA, Giorgi JV, Kaplan AH, Visscher BR, Gange S, Margolick JB, Riddler S, Phair J, Detels R, AIDS onset at high CD4+ cell levels is associated with high HIV load, Aids Research and Human Retroviruses, 16(2), 103-7, 2000 Abstract
  • Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI, Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection, Journal of Virology, 73(12), 10489-502, 1999 Abstract
  • Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF, Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy, Nature Medicine, 5(5), 512-7, 1999 Abstract
  • Rinaldo CR Jr, Gupta P, Huang XL, Fan Z, Mullins JI, Gange S, Farzadegan H, Shankarappa R, Munoz A, Margolick JB, Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection, Aids Research and Human Retroviruses, 14(16), 1423-33, 1998 Abstract
  • Gange SJ, Munoz A, Chmiel JS, Donnenberg AD, Kirstein LM, Detels R, Margolick JB, Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS, Proceedings of the National Academy of Sciences of the United States of America., 95(18), 10848-53, September 1998 Abstract
  • Munoz A, Gange SJ, Methodological issues for biomarkers and intermediate outcomes in cohort studies, Epidemiologic Reviews, 20(1), 29-42, 1998 Abstract
  • Jacobson DL, Gange SJ, Rose NR, Graham NM, Epidemiology and estimated population burden of selected autoimmune diseases in the United States, Clinical Immunology and Immunopathology, 84(3), 223-43, 1997 Abstract
  • Kensler TW, Gange SJ, Egner PA, Dolan PM, Munoz A, Groopman JD, Rogers AE, Roebuck BD, Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 6(8), 603-10, August 1997 Abstract
  • Yong FH, Taylor JM, Bryant JL, Chmiel JS, Gange SJ, Hoover D, Dependence of the hazard of AIDS on markers, Aids (london, England), 11(2), 217-28, 1997 Abstract
  • Gange SJ, Munoz A, Schrager LK, Margolick JB, Giorgi JV, Saah AJ, Rinaldo CR, Detels R, Phair JP, Design of nested studies to identify factors related to late progression of HIV infection, JAIDS, 15, S5-S9, 1997
  • Gange SJ, Jacobson LP, Munoz A, Parametric models to assess tracking of categorical high-risk sexual behaviour for HIV infection, Statistics in Medicine, 15(21-22), 2323-36; discussion, 1996 Abstract
  • Townsley-Fuchs J, Kam L, Fairhurst R, Gange SJ, Goodglick L, Giorgi JV, Sidell N, Detels R, Braun J, Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission, Journal of Clinical Investigation, 98(8), 1794-801, 1996 Abstract
  • Kee C, Gabelt BT, Gange SJ, Kaufman PL, Serum effects on aqueous outflow during anterior chamber perfusion in monkeys, Investigative Ophthalmology & Visual Science, 37(9), 1840-8, 1996 Abstract
  • Crawford KS, Gange SJ, Gabelt BT, Heideman W, Robinson JC, Hubbard WC, Kaufman PL, Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys, Investigative Ophthalmology & Visual Science, 37(7), 1348-59, 1996 Abstract
  • Pirsch JD, Ploeg RJ, Gange S, D'Alessandro AM, Knechtle SJ, Sollinger HW, Kalayoglu M, Belzer FO, Determinants of graft survival after renal transplantation, Transplantation, 61(11), 1581-6, 1996 Abstract
  • Croft MA, Oyen MJ, Gange SJ, Fisher MR, Kaufman PL, Aging effects on accommodation and outflow facility responses to pilocarpine in humans, Archives of Ophthalmology, 114(5), 586-92, 1996 Abstract
  • Wang JS, Qian GS, Zarba A, He X, Zhu YR, Zhang BC, Jacobson L, Gange SJ, Munoz A, Kensler TW, et al., Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 5(4), 253-61, April 1996 Abstract
  • Gange SJ and DeMets DL, Sequential monitoring of clinical trials with correlated responses, Biometrika, 83, 157-67, 1996
  • Pendergast J, Gange SJ, Newton MA, Lindstrom ML, Palta M, and Fisher MR, A survey of methods for analyzing clustered binary data, International Statistical Review, 64, 89-118, 1996
  • Gange SJ, Munoz A, Saéz M, and Alonso J, Use of the beta-binomial distribution to model the effect of policy changes on the appropriateness of hospital stays, Applied Statistics, 45, 371-82, 1996
  • Gange SJ, Munoz A, Wang JS, Groopman JD, Variability of molecular biomarker measurements from nonlinear calibration curves, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 5(1), 57-61, January 1996 Abstract
  • Gange SJ, Linton KL, Scott AJ, DeMets DL, Klein R, A comparison of methods for correlated ordinal measures with ophthalmic applications, Statistics in Medicine, 14(18), 1961-74, 1995 Abstract
  • Menage MJ, Croft MA, Gange SJ, Kaufman PL, epsilon-Aminocaproic acid does not inhibit outflow resistance washout in monkeys, Investigative Ophthalmology & Visual Science, 36(9), 1745-9, 1995 Abstract
  • Egner PA, Gange SJ, Dolan PM, Groopman JD, Munoz A, Kensler TW, Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz, Carcinogenesis, 16(8), 1769-73, 1995 Abstract
  • Gabelt BT, Robinson JC, Gange SJ, Kaufman PL, Superior cervical ganglionectomy in monkeys: aqueous humor dynamics and their responses to drugs, Experimental Eye Research, 60(5), 575-84, 1995 Abstract
  • Gange SJ, Generating multivariate categorical variates using the Iterative Proportional Fitting Algorithm, The American Statistician, 49, 134-8, 1995
  • Ploeg RJ, D'Alessandro AM, Groshek M, Gange SJ, Knechtle SJ, Stegall MD, Eckhoff DE, Pirsch JD, Sollinger HW, Belzer FO, Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation, Transplantation Proceedings, 26(2), 531-3, 1994 Abstract
  • Ploeg RJ, D'Alessandro AM, Groshek M, Gange SJ, Knechtle SJ, Stegall MD, Eckhoff DE, Pirsch JD, Sollinger HW, Belzer FO, Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection, 7 Suppl 1, S426-31, 1994
  • Wallow IH, Sramek SJ, Bindley CD, Darjatmoko SR, Gange SJ, Ocular renin angiotensin: EM immunocytochemical localization of prorenin, Current Eye Research, 12(10), 945-50, 1993 Abstract
  • Maloni JA, Chance B, Zhang C, Cohen AW, Betts D, Gange SJ, Physical and psychosocial side effects of antepartum hospital bed rest, Nursing Research, 42(4), 197-203, 1993 Abstract
  • Wallow IH, Bindley CD, Reboussin DM, Gange SJ, Fisher MR, Systemic hypertension produces pericyte changes in retinal capillaries, Investigative Ophthalmology & Visual Science, 34(2), 420-30, 1993 Abstract

Profile Details

Last Updated: 1/12/2010

COS Expertise ID #1156570
Reference this profile directly: http://myprofile.cos.com/sgange